Cervical Cancer Screening: Patient Perspectives on Transitioning to Primary High-Risk Human Papillomavirus Testing...

Area of Science:

• Gynecology
• Public Health
• Preventive Medicine

Background:

• Updated 2018 cervical cancer screening guidelines recommend primary human papillomavirus (HPV) testing every 5 years.
• Primary HPV screening uptake has been lower than anticipated, necessitating investigation into patient perspectives.

Purpose of the Study:

• To evaluate patient perspectives on transitioning from cotesting to primary HPV testing for cervical cancer screening.
• To identify patient concerns and preferences regarding updated screening protocols.

Main Methods:

• Conducted semistructured phone interviews with 16 individuals aged 30-65.
• Explored reactions to screening changes, cancer risk concerns, educational material feedback, and communication preferences.

Main Results:

• Patients worried that less frequent screening could lead to underdiagnosis of sexually transmitted infections (STIs).
• Participants desired clear explanations of the rationale for primary HPV testing in educational materials.
• In-clinic communication between patient and practitioner was the preferred method for discussing screening changes.

Conclusions:

• Patient concerns include differentiating cervical cancer and STI screening and potential underdiagnosis.
• Findings can guide health systems in addressing patient concerns during the shift to primary HPV testing for cervical cancer screening.